These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Strontium ranelate reduces the risk of vertebral and nonvertebral fractures in women eighty years of age and older. Seeman E; Vellas B; Benhamou C; Aquino JP; Semler J; Kaufman JM; Hoszowski K; Varela AR; Fiore C; Brixen K; Reginster JY; Boonen S J Bone Miner Res; 2006 Jul; 21(7):1113-20. PubMed ID: 16813532 [TBL] [Abstract][Full Text] [Related]
5. Five years treatment with strontium ranelate reduces vertebral and nonvertebral fractures and increases the number and quality of remaining life-years in women over 80 years of age. Seeman E; Boonen S; Borgström F; Vellas B; Aquino JP; Semler J; Benhamou CL; Kaufman JM; Reginster JY Bone; 2010 Apr; 46(4):1038-42. PubMed ID: 20026265 [TBL] [Abstract][Full Text] [Related]
6. Protelos: nonvertebral and hip antifracture efficacy in postmenopausal osteoporosis. Adami S Bone; 2006 Feb; 38(2 Suppl 1):23-7. PubMed ID: 16434247 [TBL] [Abstract][Full Text] [Related]
7. Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: Results of a five-year, randomized, placebo-controlled trial. Reginster JY; Felsenberg D; Boonen S; Diez-Perez A; Rizzoli R; Brandi ML; Spector TD; Brixen K; Goemaere S; Cormier C; Balogh A; Delmas PD; Meunier PJ Arthritis Rheum; 2008 Jun; 58(6):1687-95. PubMed ID: 18512789 [TBL] [Abstract][Full Text] [Related]
8. Strontium ranelate: an increased bone quality leading to vertebral antifracture efficacy at all stages. Ortolani S; Vai S Bone; 2006 Feb; 38(2 Suppl 1):19-22. PubMed ID: 16455319 [TBL] [Abstract][Full Text] [Related]
9. Osteoporosis: from early fracture prevention to better bone health with strontium ranelate. Cortet B Rheumatology (Oxford); 2009 Oct; 48 Suppl 4():iv14-9. PubMed ID: 19783589 [TBL] [Abstract][Full Text] [Related]
10. A new treatment for post-menopausal osteoporosis: strontium ranelate. Rizzoli R J Endocrinol Invest; 2005; 28(8 Suppl):50-7. PubMed ID: 16323829 [TBL] [Abstract][Full Text] [Related]
11. Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study. Reginster JY; Seeman E; De Vernejoul MC; Adami S; Compston J; Phenekos C; Devogelaer JP; Curiel MD; Sawicki A; Goemaere S; Sorensen OH; Felsenberg D; Meunier PJ J Clin Endocrinol Metab; 2005 May; 90(5):2816-22. PubMed ID: 15728210 [TBL] [Abstract][Full Text] [Related]
12. Clodronate reduces vertebral fracture risk in women with postmenopausal or secondary osteoporosis: results of a double-blind, placebo-controlled 3-year study. McCloskey E; Selby P; Davies M; Robinson J; Francis RM; Adams J; Kayan K; Beneton M; Jalava T; Pylkkänen L; Kenraali J; Aropuu S; Kanis JA J Bone Miner Res; 2004 May; 19(5):728-36. PubMed ID: 15068495 [TBL] [Abstract][Full Text] [Related]
13. Long-term treatment of postmenopausal osteoporosis with strontium ranelate: results at 8 years. Reginster JY; Bruyère O; Sawicki A; Roces-Varela A; Fardellone P; Roberts A; Devogelaer JP Bone; 2009 Dec; 45(6):1059-64. PubMed ID: 19679207 [TBL] [Abstract][Full Text] [Related]
14. Relationship between pretreatment bone resorption and vertebral fracture incidence in postmenopausal osteoporotic women treated with risedronate. Seibel MJ; Naganathan V; Barton I; Grauer A J Bone Miner Res; 2004 Feb; 19(2):323-9. PubMed ID: 14969403 [TBL] [Abstract][Full Text] [Related]
15. Treatment with alendronate prevents fractures in women at highest risk: results from the Fracture Intervention Trial. Ensrud KE; Black DM; Palermo L; Bauer DC; Barrett-Connor E; Quandt SA; Thompson DE; Karpf DB Arch Intern Med; 1997 Dec 8-22; 157(22):2617-24. PubMed ID: 9531231 [TBL] [Abstract][Full Text] [Related]
16. [Strontium ranelate: a novel concept for the treatment of osteoporosis]. Dimai HP Wien Klin Wochenschr; 2005 Nov; 117(21-22):728-38. PubMed ID: 16416353 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of pharmacological agents in managing osteoporosis in the old old: review of the evidence. Inderjeeth CA; Foo AC; Lai MM; Glendenning P Bone; 2009 May; 44(5):744-51. PubMed ID: 19130909 [TBL] [Abstract][Full Text] [Related]